铜陵洁雅生物科技股份有限公司 关于使用部分闲置募集资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 铜陵洁雅生物科技股份有限公司（以下简称"公司"）于 2025 年 1 月 21 日召开第五届董事会第二十四次会议和第五届监事会第二十二次会议，于 2025 年 2 月 10 日召开 2025 年第一次临时股东大会，审议通过了《关于使用部分闲置 募集资金进行现金管理的议案》，同意在确保不影响募集资金投资项目建设和公 司正常经营的前提下，使用额度不超过人民币 6 亿元的部分闲置募集资金（含超 募资金）进行现金管理，用于购买安全性高、流动性好、期限不超过 12 个月的 短期投资理财产品。使用期限自股东大会审议通过之日起 12 个月内有效。在上 述额度和期限内，资金可循环滚动使用，并授权董事长在上述额度和期限范围内 行使相关投资决策权并签署相关文件，公司财务部门具体办理相关事宜。具体内 容详见公司于 2025 年 1 月 22 日在巨潮资讯网（www.cninfo.com.cn）披露的《关 于使用部分闲置募集资金进行现金管理的公告》（公告编号： ...

Summary of the Conference Call for Jieja Co., Ltd. Company Overview - Jieja Co., Ltd. focuses on the wet wipes market, with a strategic shift towards international clients and a plan to expand production capacity in the U.S. by 2026 [2][5][7]. Key Points Industry and Market Dynamics - The wet wipes market is experiencing rapid growth in demand, particularly in the international market, despite intense domestic competition leading to lower profit margins [10][11]. - The global wet wipes contract manufacturing market is estimated to be around 100 billion RMB, with the U.S. accounting for nearly 40% of the global market share [26]. Revenue and Profitability - Jieja Co., Ltd. has seen a slight revenue increase in the first half of the year compared to last year, with expectations for accelerated growth in the second half, particularly in net profit [3][34]. - The company anticipates a revenue growth of approximately 20%-30% year-on-year by 2025, driven by an optimized customer and order structure [4][34]. Customer Structure and Orders - The customer base has shifted from primarily international brands during the pandemic to domestic e-commerce clients, with a recent return to international clients like Kimberly-Clark and Procter & Gamble [2][4]. - The current export distribution is approximately 30% to Europe, 30% to Australia and Southeast Asia, 10% to the U.S., and 30% to the domestic market [6]. Production Capacity and Expansion Plans - The company maintains a high capacity utilization rate of 80%-90% and can quickly ramp up production through continuous shifts if urgent orders arise [2][30]. - Plans to establish a factory in the U.S. are underway, expected to be operational by early 2026, despite higher labor costs, which are projected to yield a gross margin of about 15% and a net margin of 7-8% [8][9]. Pricing and Cost Management - Jieja Co., Ltd. employs a cost-plus pricing strategy with clients, allowing for price adjustments in response to fluctuations in raw material costs and exchange rates [14]. - The company has established a mechanism to adjust prices when raw material or exchange rate changes exceed certain thresholds [14]. Competitive Landscape - The company has built strong relationships with major clients through long-term cooperation and trust, which is a significant competitive advantage [22]. - The domestic wet wipes market is characterized by intense competition and low profit margins, prompting Jieja Co., Ltd. to focus on international markets for growth [11][25]. Future Outlook - The company is exploring further expansion into new product categories and markets, particularly in the U.S. and Southeast Asia, to leverage existing client relationships [27][17]. - Jieja Co., Ltd. is considering additional incentive plans to enhance internal momentum and performance [33]. Challenges and Risks - The company faces challenges from fluctuating raw material prices and intense competition in the domestic market, which could impact profitability [11][14]. - The uncertainty in client demand and the speed of order transitions from in-house production to contract manufacturing pose risks to growth projections [28]. Conclusion Jieja Co., Ltd. is strategically positioning itself to capitalize on international market opportunities while managing domestic competition. The company's focus on optimizing its customer base and expanding production capabilities, particularly in the U.S., is expected to drive significant revenue and profit growth in the coming years.

证券代码：301108 证券简称：洁雅股份 公告编号：2025-051 员会委员并聘任高级管理人员及证券事务代表的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 铜陵洁雅生物科技股份有限公司（以下简称"公司"）于 2025 年 7 月 14 日召开了 2025 年第三次临时股东会，审议通过了《关于董事会换届选举暨选举 第六届董事会非独立董事的议案》《关于董事会换届选举暨选举第六届董事会独 立董事的议案》，同意选举蔡英传先生、冯燕女士、叶英女士、俞彦诚先生、杨 凡龙先生为公司第六届董事会非独立董事，选举何文龙先生、赵波先生、陈彦先 生为公司第六届董事会独立董事，与公司职工代表大会选举产生的职工代表董事 王婷女士共同组成公司第六届董事会，任期自公司 2025 年第三次临时股东会审 议通过之日起三年。 铜陵洁雅生物科技股份有限公司 关于董事会完成换届选举及选举董事长、第六届董事会各专门委 同日，公司召开了第六届董事会第一次会议，审议通过了《关于选举第六届 董事会董事长的议案》《关于选举第六届董事会各专门委员会委员的议案》《关 于聘任公司总经理的议案》《关于聘任 ...

证券代码：301108 证券简称：洁雅股份 公告编号：2025-050 铜陵洁雅生物科技股份有限公司 第六届董事会第一次会议决议公告 根据《公司章程》规定，代表公司执行公司事务的董事为公司的法定代表人， 董事长为代表公司执行公司事务的董事，即董事长为公司法定代表人。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 铜陵洁雅生物科技股份有限公司（以下简称"公司"）第六届董事会第一次 会议于 2025 年 7 月 14 日在公司会议室召开。公司于 2025 年 7 月 14 日召开 2025 年第三次临时股东会，完成了董事会换届选举工作。为确保新一届董事会尽快投 入工作，经全体董事一致同意，决定于 2025 年 7 月 14 日召开的 2025 年第三次 临时股东会结束后，在公司会议室以现场结合通讯方式召开第六届董事会第一次 会议。本次会议通知豁免时间要求，并以口头方式向全体董事送达。本次会议应 出席董事 9 人，实际出席董事 9 人（其中独立董事何文龙先生、赵波先生、陈彦 先生、非独立董事俞彦诚先生以通讯表决方式出席）。本次会议由全体董事 ...

天禾律师 股东会法律意见书 安徽天禾律师事务所 关于铜陵洁雅生物科技股份有限公司 2025 年第三次临时股东会法律意见书 天律意 2025 第 01818 号 致：铜陵洁雅生物科技股份有限公司 根据《中华人民共和国公司法》（下称"《公司法》"）、《中华人民共和国 证券法》（下称"《证券法》"）、中国证券监督管理委员会《上市公司股东会规 则》（下称"《股东会规则》"）以及《铜陵洁雅生物科技股份有限公司章程》（下 称"《公司章程》"）的有关规定，安徽天禾律师事务所接受铜陵洁雅生物科技股 份有限公司（下称"公司"）委托，指派张大林、冉合庆律师（下称"天禾律师"） 出席公司 2025 年第三次临时股东会（下称"本次股东会"），并对本次股东会相 关事项进行见证，出具法律意见。 本法律意见书是天禾律师根据对本次股东会事实的了解及对我国现行法律、 法规和规范性文件的理解而出具的。 天禾律师同意将本法律意见书作为本次股东会的法定必备文件予以公告，并 依法对所出具的法律意见书承担责任。 天禾律师根据《证券法》相关规定的要求，按照律师行业公认的业务标准、 道德规范和勤勉尽责精神，对本次股东会的召集、召开、与会人员资格、表决程 序 ...

证券代码：301108 证券简称：洁雅股份 公告编号：2025-049 铜陵洁雅生物科技股份有限公司 2025年第三次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1. 本次股东会未出现否决议案的情形。 2. 本次股东会不涉及变更以往股东会已通过的决议。 3.本次股东会的股权登记日（2025 年 7 月 9 日）与公司 2024 年度权益分派 实施的股权登记日为同一日。鉴于本次权益分派涉及资本公积金转增股本（新增 股份上市日为 2025 年 7 月 10 日），出席本次股东会的股东所持表决权股份数以 2025 年 7 月 9 日收市后在中国证券登记结算有限责任公司深圳分公司登记在册 的股份数量为准。 一、会议召开情况 1、会议召开时间 （1）现场会议召开时间：2025 年 7 月 14 日（星期一）14:30。 （2）网络投票时间：2025 年 7 月 14 日（星期一）。 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 7 月 14 日 9:15-9:25，9:30-11:30，13:00-15:00 ...

Core Points - The company has approved a profit distribution and capital reserve transfer plan for the fiscal year 2024, which includes a cash dividend and a stock increase for shareholders [1][2] Profit Distribution and Capital Reserve Transfer Plan - The profit distribution plan involves a cash dividend of 1.00 RMB per 10 shares, totaling 8,039,732.30 RMB (including tax), based on a total share capital of 80,397,323 shares [1][2] - The company will not issue bonus shares but will increase the share capital by transferring 4 shares for every 10 shares held, resulting in an increase of 32,158,929 shares, bringing the total share capital to 112,556,252 shares [1][2] Dividend Payment Date and Recipients - The dividend will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited Shenzhen Branch as of July 9, 2025 [3] Share Capital Structure Changes - Before the distribution, the total share capital was 80,397,323 shares, and after the transfer, it will be 112,556,252 shares [4] - The company will handle any legal responsibilities related to cash dividend distribution [3] Adjustments and Consultations - The company will adjust relevant parameters post-distribution, including the minimum selling price for shares after the ex-dividend date, set at 55.56 RMB per share [4] - For inquiries, the company has provided contact details for its securities department [6]

证券代码：301108 证券简称：洁雅股份 公告编号：2025-048 铜陵洁雅生物科技股份有限公司 2024年度分红派息、转增股本实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股东大会审议通过利润分配及资本公积金转增股本方案等情况 1.2025年5月16日，铜陵洁雅生物科技股份有限公司（以下简称"公司"）2024 年年度股东大会审议通过了《关于2024年度利润分配和资本公积金转增股本方案 的议案》，2024年度利润分配方案为：公司以总股本80,397,323股为基数，拟向 全体股东每10股派发现金红利1.00元（含税），合计派发现金红利8,039,732.30 元人民币（含税），剩余未分配利润暂不分配转入以后年度；不送红股；以资本 公积金向全体股东每10股转增4股，共计转增32,158,929股，转增后公司总股本将 增加至112,556,252 股（注：转增股数系公司根据实际计算结果四舍五入所得， 最终转增数量以中国证券登记结算有限公司实际转增结果为准）。本次利润分配 和资本公积金转增股本方案公告后至实施权益分派股权登记日期间，若公司总股 本 ...

Group 1 - Aike Cyber (688719.SH) shareholders Dachen Chuangtong and Dachen Chuanghong reduced their holdings by 2,298,151 shares, accounting for 1.99% of the total share capital, and did not complete the planned reduction [1] - Benchuan Intelligent (300964.SZ) controlling shareholder Dong Xiaojun reduced his holdings by 355,787 shares, accounting for 0.4582% of the total share capital, bringing his shareholding down to 21.64% [1] - Changlian Co., Ltd. (603648.SH) completed its reduction plan by selling 3,624,050 shares, which is 1% of the total share capital [1] Group 2 - Chuan Yi Technology (002866.SZ) controlling shareholder Zou Weimin and his concerted party reduced their holdings, with Zou's shareholding dropping to 48.53% [2] - Daoshi Technology (300409.SZ) controlling shareholder Rong Jihua plans to reduce his holdings by up to 15,416,611 shares, accounting for 1.97% of the total share capital [2] - Electric Alloy (300697.SZ) completed its reduction plan by selling 2,741,390 shares, which is 0.63% of the total share capital [2] Group 3 - Fujirei (688272.SH) shareholders Suzhou Kongkong, Suzhou Zhaorong, and Shanghai Zhaoren reduced their holdings by 1,215,618 shares, 1,463,490 shares, and 44,944 shares, accounting for 1.60%, 1.93%, and 0.06% of the total share capital respectively [3] - Gaoweida (300465.SZ) controlling shareholder Yingtan Yinggao Investment Consulting Co., Ltd. reduced its holdings by 4,261,700 shares, accounting for 0.96% of the total share capital, bringing its shareholding down to 22.00% [3] - Haizheng Materials (688203.SH) shareholder Sinopec Capital plans to reduce its holdings by up to 3,525,600 shares, accounting for 1.74% of the total share capital [3] Group 4 - Hangyu Micro (300053.SZ) shareholder Yan Jun reduced his holdings by 3,930,000 shares, accounting for 0.56% of the total share capital [4] - He Shi Eye Hospital (301103.SZ) shareholder Advanced Manufacturing Industry Investment Fund plans to reduce its holdings by up to 3,106,074 shares, accounting for 2% of the total share capital [4] - He Yuan Gas (002971.SZ) shareholder Baishide Chuangye completed its reduction plan by selling 854,064 shares, which is 0.415% of the total share capital [4] Group 5 - Huaren Health (301408.SZ) shareholder Saifu Investment reduced its holdings by 2,107,696 shares, accounting for 0.53% of the total share capital [5] - Jiangsu Boyun (301003.SZ) shareholder Gong Wei reduced his holdings by 1,558,900 shares, accounting for 1.57% of the total share capital [5] - Jeya Co., Ltd. (301108.SZ) shareholders Mingyuan Fund and its concerted party did not reduce their holdings, and the reduction plan period expired [5] Group 6 - Longxin General (603766.SH) directors plan to reduce their holdings by up to 350,000 shares and 100,000 shares, accounting for 0.0170% and 0.0049% of the total share capital respectively [6] - Ruchuang Micro-Nano (688002.SH) shareholder Li Weicheng plans to reduce his holdings by up to 8,000,000 shares, accounting for 1.75% of the total share capital [6] - Shilan Micro (600460.SH) shareholder Luo Huabing plans to reduce his holdings by up to 500,000 shares, accounting for 0.03005% of the total share capital [6] Group 7 - Tongfu Microelectronics (002156.SZ) shareholder National Integrated Circuit Industry Investment Fund reduced its holdings by 15,175,969 shares, accounting for 1% of the total share capital [7] - Wangzi New Materials (002735.SZ) controlling shareholder Wang Jinjun reduced his holdings by 9,717,874 shares, accounting for 2.54% of the total share capital [7] - Xingye Co., Ltd. (603928.SH) shareholder Shen Genzhen reduced his holdings by 2,620,000 shares, accounting for 1.00% of the total share capital [7] Group 8 - Yikang Co., Ltd. (301085.SZ) controlling shareholder concerted party reduced its holdings by 633,700 shares, accounting for 0.73% of the total share capital [8] Group 9 - Yiming Pharmaceutical (002826.SZ) major shareholder Zhou Zhan reduced his holdings by 3,586,777 shares, accounting for 1.88% of the total share capital [9] - Yiming Pharmaceutical (002826.SZ) director Xi Ke reduced his holdings by 283,862 shares, accounting for 0.15% of the total share capital [9] - Youyan Powder Materials (688456.SH) concerted party reduced its holdings by 1,030,000 shares, accounting for 0.99% of the total share capital [9] Group 10 - Zhongma Transmission (603767.SH) directors plan to reduce their holdings through block trading and centralized bidding [10] - Zhongqi Co., Ltd. (301215.SZ) shareholder Jiangsu Yueda Group did not reduce its holdings, and the reduction plan period expired [10]

证券代码：301108 证券简称：洁雅股份 公告编号：2025-047 铜陵洁雅生物科技股份有限公司 关于持股5%以上股东及其一致行动人 减持计划期限届满未减持股份的公告 持股 5%以上股东铜陵明源循环经济产业创业投资基金中心（有限合伙）及 其一致行动人苏州工业园区中亿明源创业投资中心（有限合伙）保证向本公司提 供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 铜陵洁雅生物科技股份有限公司（以下简称"公司"）于2025年3月7日披露 了《关于持股5%以上股东及其一致行动人减持股份计划的预披露公告》（公告编 号：2025-019），公司持股5%以上股东铜陵明源循环经济产业创业投资基金中心 （有限合伙）（以下简称"明源基金"）及其一致行动人苏州工业园区中亿明源 创业投资中心（有限合伙）（以下简称"中亿明源"）计划在上述公告披露之日 起15个交易日后的3个月内以集中竞价或大宗交易方式减持其持有的首次公开发 行前股份总数不超过3,979,667股，占公司总股本比例不超过4.95%。 公司于2025年6月30日收到明源基金及其一致行动 ...